Universal Historical Income Statement

601231 Stock

15.29 0.66 4.51%

Historical analysis of Universal Scientific income statement accounts such as Selling General Administrative of 718.4 M, Total Revenue of 32.9 B or Operating Income of 1.3 B can show how well Universal Scientific Industrial performed in making a profits. Evaluating Universal Scientific income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Universal Scientific's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Universal Scientific latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Universal Scientific is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Universal Income Statement Analysis

Universal Scientific Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Universal Scientific shareholders. The income statement also shows Universal investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Universal Scientific Income Statement Chart

At present, Universal Scientific's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 718.4 M, whereas Total Revenue is forecasted to decline to about 32.9 B.

Selling General Administrative Total Revenue Operating Income Net Income Applicable To Common Shares

Total Revenue

Total revenue comprises all receipts Universal Scientific generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Universal Scientific operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Universal Scientific Industrial is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.

Most accounts from Universal Scientific's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Universal Scientific current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Operating Income	2.2B	3.4B	2.5B	1.3B
Total Revenue	55.3B	68.5B	60.8B	32.9B

Operating Income Total Revenue

Universal Scientific income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		-0.11	-0.19	-0.11	-0.2	-0.18	-0.39	-0.15	-0.13	0.23	-0.17	-0.31	-0.04	-0.21	-0.2	-0.09	-0.09	-0.27	-0.27	-0.05
Total Revenue	-0.11		0.96	1.0	0.95	0.95	0.77	0.98	0.96	0.57	0.93	0.75	0.94	0.78	-0.02	0.73	-0.82	0.53	0.77	0.87
Operating Income	-0.19	0.96		0.96	0.99	0.99	0.78	0.94	0.96	0.59	0.96	0.75	0.93	0.74	-0.11	0.82	-0.77	0.49	0.78	0.83
Cost Of Revenue	-0.11	1.0	0.96		0.94	0.95	0.77	0.98	0.96	0.57	0.92	0.75	0.94	0.78	-0.02	0.72	-0.82	0.54	0.77	0.86
Income Before Tax	-0.2	0.95	0.99	0.94		1.0	0.76	0.92	0.94	0.52	0.96	0.71	0.9	0.76	-0.05	0.84	-0.73	0.44	0.73	0.78
Net Income	-0.18	0.95	0.99	0.95	1.0		0.75	0.93	0.94	0.52	0.96	0.71	0.9	0.76	-0.05	0.83	-0.74	0.45	0.74	0.79
Income Tax Expense	-0.39	0.77	0.78	0.77	0.76	0.75		0.83	0.85	0.52	0.81	0.98	0.82	0.68	-0.21	0.68	-0.83	0.88	0.77	0.83
Research Development	-0.15	0.98	0.94	0.98	0.92	0.93	0.83		0.97	0.54	0.93	0.81	0.94	0.75	0.01	0.72	-0.85	0.63	0.74	0.85
Gross Profit	-0.13	0.96	0.96	0.96	0.94	0.94	0.85	0.97		0.61	0.98	0.85	0.98	0.75	-0.11	0.82	-0.89	0.63	0.8	0.9
Other Operating Expenses	0.23	0.57	0.59	0.57	0.52	0.52	0.52	0.54	0.61		0.56	0.55	0.63	0.32	-0.74	0.53	-0.62	0.44	0.59	0.61
Net Income From Continuing Ops	-0.17	0.93	0.96	0.92	0.96	0.96	0.81	0.93	0.98	0.56		0.81	0.95	0.74	-0.11	0.9	-0.82	0.56	0.78	0.84
Ebit	-0.31	0.75	0.75	0.75	0.71	0.71	0.98	0.81	0.85	0.55	0.81		0.84	0.61	-0.24	0.68	-0.87	0.92	0.82	0.87
Total Operating Expenses	-0.04	0.94	0.93	0.94	0.9	0.9	0.82	0.94	0.98	0.63	0.95	0.84		0.72	-0.12	0.79	-0.92	0.66	0.84	0.95
Total Other Income Expense Net	-0.21	0.78	0.74	0.78	0.76	0.76	0.68	0.75	0.75	0.32	0.74	0.61	0.72		0.18	0.51	-0.65	0.48	0.57	0.68
Minority Interest	-0.2	-0.02	-0.11	-0.02	-0.05	-0.05	-0.21	0.01	-0.11	-0.74	-0.11	-0.24	-0.12	0.18		-0.34	0.17	-0.21	-0.24	-0.19
Tax Provision	-0.09	0.73	0.82	0.72	0.84	0.83	0.68	0.72	0.82	0.53	0.9	0.68	0.79	0.51	-0.34		-0.67	0.39	0.65	0.69
Net Interest Income	-0.09	-0.82	-0.77	-0.82	-0.73	-0.74	-0.83	-0.85	-0.89	-0.62	-0.82	-0.87	-0.92	-0.65	0.17	-0.67		-0.77	-0.72	-0.95
Interest Income	-0.27	0.53	0.49	0.54	0.44	0.45	0.88	0.63	0.63	0.44	0.56	0.92	0.66	0.48	-0.21	0.39	-0.77		0.71	0.76
Ebitda	-0.27	0.77	0.78	0.77	0.73	0.74	0.77	0.74	0.8	0.59	0.78	0.82	0.84	0.57	-0.24	0.65	-0.72	0.71		0.87
Reconciled Depreciation	-0.05	0.87	0.83	0.86	0.78	0.79	0.83	0.85	0.9	0.61	0.84	0.87	0.95	0.68	-0.19	0.69	-0.95	0.76	0.87

Click cells to compare fundamentals

Universal Scientific Account Relationship Matchups

Universal Scientific income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	80.8M	90.2M	201.3M	235.0M	400.2M	420.2M
Selling General Administrative	541.7M	1.4B	1.6B	602.4M	398.1M	718.4M
Total Revenue	37.2B	47.7B	55.3B	68.5B	60.8B	32.9B
Operating Income	1.2B	2.0B	2.2B	3.4B	2.5B	1.3B
Cost Of Revenue	33.5B	42.7B	49.8B	61.3B	54.9B	29.4B
Income Before Tax	1.4B	2.0B	2.1B	3.5B	2.2B	1.4B
Net Income Applicable To Common Shares	1.3B	1.7B	1.9B	3.1B	3.5B	3.7B
Net Income	1.3B	1.7B	1.9B	3.1B	1.9B	1.2B
Income Tax Expense	172.7M	240.0M	282.2M	417.2M	479.8M	503.8M
Research Development	1.4B	1.6B	1.6B	2.0B	1.8B	1.5B
Gross Profit	3.7B	5.0B	5.5B	7.2B	5.9B	4.8B
Other Operating Expenses	40.8M	13.4M	61.7M	49.8M	57.3M	42.8M
Net Income From Continuing Ops	1.3B	1.7B	1.9B	3.1B	1.9B	1.7B
Ebit	1.3B	1.9B	2.1B	3.5B	4.0B	4.2B
Total Operating Expenses	36.0B	45.7B	53.1B	65.1B	58.3B	45.0B
Minority Interest	31.2M	(978.4K)	1.3M	(22.7K)	(1.9M)	(1.8M)
Tax Provision	172.7M	240.0M	282.2M	417.2M	240.0M	277.3M
Net Interest Income	(35.6M)	(95.8M)	(203.4M)	(155.2M)	(180.0M)	(171.0M)
Interest Income	48.3M	60.4M	67.8M	88.0M	236.5M	248.4M
Ebitda	2.0B	2.6B	2.3B	4.7B	5.4B	2.8B
Reconciled Depreciation	515.7M	596.3M	972.8M	994.2M	1.1B	791.2M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Universal Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Universal Historical Income Statement

About Universal Income Statement Analysis

Universal Scientific Income Statement Chart

Total Revenue

Operating Income

Net Income Applicable To Common Shares

Universal Scientific income statement Correlations

Universal Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Universal Scientific income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Universal Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Total Revenue
Net Income	+ 1.0	Income Before Tax
Income Before Tax	+ 0.99	Operating Income
Net Income	+ 0.99	Operating Income
Research Development	+ 0.98	Total Revenue
Research Development	+ 0.98	Cost Of Revenue

Reconciled Depreciation	- 0.95	Net Interest Income
Net Interest Income	- 0.92	Total Operating Expenses
Net Interest Income	- 0.89	Gross Profit
Net Interest Income	- 0.87	Ebit
Net Interest Income	- 0.85	Research Development
Net Interest Income	- 0.83	Income Tax Expense